Serve Robotics Inc. /DE/ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Serve Robotics Inc. /DE/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $207.5K | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | $107.8K | Feb 29, 2024 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.65M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.81M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $207.5K | Mar 6, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($15.38M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($75.0K) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($1.52M) | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | ($1.04M) | Feb 29, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($101.36M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($39.19M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($24.81M) | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | ($21.86M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($54.6K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($18.1K) | Mar 31, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($112.77M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($38.29M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($20.73M) | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | ($20.95M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($54.6K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($18.1K) | Mar 31, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.27M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $24.26M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $9.95M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $13.57M | Feb 29, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($80.24M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($21.54M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($15.97M) | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | ($21.40M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($51.6K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($13.1K) | Mar 31, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.33M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $10.25M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $4.9K | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $3.64M | Feb 29, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $367.75M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $139.60M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $2.80M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $8.54M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $271 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $9.4K | Mar 31, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.01M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $7.92M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $6.84M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $21.00M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $72.5K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $27.0K | Mar 31, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $350.74M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $131.68M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | ($4.03M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | ($12.45M) | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $8.32M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | ($17.6K) | Mar 31, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.53M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Mar 12, 2026 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($208.89M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($107.53M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($68.33M) | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | ($43.52M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($72.7K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($18.1K) | Mar 31, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $106.24M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $123.27M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $6.8K | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $2.72M | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | $9.4K | Apr 28, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | (1) | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | (3) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | (1) | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | (3) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 74.73M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 51.29M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 24.51M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | 6.83M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 5.00M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 5.00M | Mar 31, 2022 |